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Abstract (150) 45 
The development of LBG-based nanoparticles intending an application in oral 
immunization is presented. Nanoparticle production occurred by mild polyelectrolyte 
complexation, requiring the chemical modification of LBG. Three LBG derivatives 
were synthesized, namely a positively charged ammonium derivative (LBGA) and 
negatively charged sulfate (LBGS) and carboxylate (LBGC) derivatives. These were 50 
characterized by Fourier-transform infrared spectroscopy, elemental analysis, nuclear 
magnetic resonance spectroscopy, gel permeation chromatography, and x-ray 
diffraction. As a pharmaceutical application was aimed, a toxicological analysis of the 
derivatives was performed by both MTT test and LDH release assay. 
Several nanoparticle formulations were produced using LBGA or chitosan (CS) as 55 
positively charged polymers, and LBGC or LBGS as negatively charged counterparts, 
producing nanoparticles with adequate properties regarding an application in oral 
immunization. 
 
Highlights 3 to 5 bullet points (max 85 characters each, including spaces) 60 
• LBG charged derivatives (ammonium, sulfated and carboxylated) were 
synthesized;  
• LBG-based nanoparticles, adequate for drug delivery applications, were 
produced; 
• Only the LBG ammonium derivative demonstrated severe cytotoxicity in Caco-2 65 
cells; 
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1. Introduction 
The recent decades have brought to the market many new biomolecules that have been 
identified as having therapeutic potential. These molecules, which include from proteins 
and peptides to antigens and nucleic acids, are usually called biopharmaceuticals, 75 
meaning that they are biological in nature and manufactured using biotechnology 
(Rader, 2008). Although therapeutically promising, biopharmaceuticals are very 
unstable compounds and their administration is extremely challenging, due to inherent 
physicochemical and biopharmaceutical properties (Alonso, 2004; Kammona & 
Kiparissides, 2012). Moreover, the therapeutic action of proteins and protein-based 80 
molecules is not only limited by the potential degradation in biological environments, 
but also compromised by their low ability to reach the therapeutic site of action 
(Antosova, Mackova, Kral & Macek, 2009; Casettari & Illum, 2014; Kammona & 
Kiparissides, 2012). As such, a meaningful challenge for current pharmaceutical 
scientists has been the need to develop suitable vehicles that permit delivering 85 
macromolecules through alternative routes of administration. Polymeric nanoparticles 
have been demonstrating to be very promising in oral delivery of biopharmaceuticals, as 
many works report their effective role in the enhancement of oral drug bioavailability 
by facilitating cell internalization (Csaba, Garcia-Fuentes & Alonso, 2006; Kadiyala, 
Loo, Roy, Rice & Leong, 2010). Their reduced size provides an intimate contact with 90 
epithelia and, in several occasions, they have shown the capacity to carry the 
encapsulated molecules through the epithelium (Csaba, Garcia-Fuentes & Alonso, 2006; 
de la Fuente, Csaba, Garcia-Fuentes & Alonso, 2008). With respect to oral vaccination, 
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the design of suitable antigen delivery systems should focus on optimizing antigen 
association efficiency, ensuring the maintenance of its stability during association, 95 
tailoring release kinetics and eliciting high levels of long-lasting antibody and cellular 
immune responses. Nanoparticles may provide extra benefits in oral immunization 
strategies, because Peyer’s Patches (PPs) have shown to be a predominant site for 
uptake of particulates (Lavelle & O'Hagan, 2006). Given their role in intestinal 
mediated immunization, M cells are the primary targets to consider. A careful selection 100 
of nanoparticle matrix materials may further help on the potentiation of an immune 
response. In this context, mucoadhesive polymers can contribute to the prolongation on 
the intestinal residence time (Arca, Gunbeyaz & Senel, 2009), potentiating the uptake 
by M cells. 
Locust bean gum (LBG), also known as carob bean gum, is obtained from the 105 
endosperm of carob tree (Ceratonia siliqua) seeds, where it acts as reserve material. It is 
reported as biocompatible, biosorbable, biodegradable, non-teratogenic and non-
mutagenic, presenting a mucoadhesive behaviour, and its degradation products are 
excreted readily (Dionísio & Grenha, 2012; Malik, Arora & Singh, 2011a; Pollard et al., 
2007; Sudhakar, Kuotsu & Bandyopadhyay, 2006; Surana, Munday, Cox & Khan, 110 
1998). Classified by the FDA as a GRAS (Generally Recognized as Safe) material, it is 
approved in most areas of the world for use in the food industry as thickener, stabilizer, 
emulsifier, and gelling agent (E410). It is also used in the pharmaceutical industry as 
excipient in drug formulations, and in biomedical applications (Barak & Mudgil, 2014; 
Dionísio & Grenha, 2012; Kawamura, 2008; Prajapati, Jani, Moradiya, Randeria & 115 
Nagar, 2013). LBG is mainly comprised of high molecular weight (approximately 50 
000 – 3 000 000 Da) neutral galactomannan, consisting in a linear chain of (1-4)-linked 
-D-mannopyranosyl units with (1-6)-linked -D-galactopyranosyl residues as side 
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chains. The mannose and galactose contents have been reported to be 73-86% and 27-
14%, respectively, which corresponds to a mannose:galactose (M/G) ratio of 120 
approximately 4:1 (Kawamura, 2008).  
Recently, there has been a growing interest in the chemical functionalization of 
polysaccharides, particularly those non-animal derived, mainly by making use of the 
free hydroxyl groups distributed along their backbone, in order to create derivatives 
with properties tailored for the desired applications (Mizrahy & Peer, 2012).  125 
In this paper, the chemical modification of LBG, aimed at obtain charged derivatives 
intended for the development of nanoparticulate carriers by polyelectrolyte 
complexation, is described. Two anionic (sulfate - LBGS and carboxylate - LBGC) and 
one cationic (trimethylammonium - LBGA) derivatives were prepared (Figure 1). The 
former were combined with the positively charged polysaccharide chitosan (CS) and the 130 




Figure 1 – Scheme of the chemical modifications introduced in LBG. 
 
2. Materials and methods 135 
2.1. Materials 
Locust bean gum (LBG) was a kind gift from Industrial Farense (Faro, Portugal). Due 
to the presence of around 3-7% protein in commercial LBG (Kawamura, 2008), a 
LBGC: R1 = COOH / CH2OH; R2 = OH 
LBGS: R1 = CH2OSO3
- / CH2OH; R2 = OSO3
- / OH
LBGA: R1 = CH2OCH2CH(OH)CH2N
+(CH3)3 / CH2OH;
            R2 = OCH2CH(OH)CH2N
+(CH3)3 / OH
1. TEMPO, NaBr, NaClO (10-15%)
     pH=9, 0 ºC, 4 h
2. NaBH4
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purification step, based on previously published protocols (Bouzouita et al., 2007; 
Wang, Wang & Sun, 2002), was performed prior to use. This purified LBG was the 140 
material used for subsequent work, unless stated otherwise. Chitosan (CS, low 
molecular weight, deacetylation degree = 75 – 85%), glacial acetic acid, chlorosulfuric 
acid (HClSO3), dimethylformamide (DMF), N-glycidyl-N,N,N-trimethylammonium 
chloride (GTMAC), sodium hydroxide (NaOH), potassium hydroxide (KOH), 2,2,6,6-
tetramethypiperidine-1-oxyl (TEMPO), sodium bromide (NaBr), sodium hypochlorite 145 
solution (NaClO), sodium borohydride (NaBH4), sodium nitrate (NaNO3), sodium 
dihydrogen phosphate (NaH2PO4), sodium azide (NaN3), dialysis tubing (pore size 
2000 Da), phosphotungstate dibasic hydrate, glycerol, phosphate buffered saline (PBS) 
pH 7.4 tablets, Dulbecco’s modified Eagle’s medium (DMEM), penicillin/streptomycin 
(10000 units/mL, 10000 µg/mL), non-essential amino acids, L-glutamine 200 mM, 150 
trypsin-EDTA solution (2.5 g/L trypsin, 0.5 g/L EDTA), trypan blue solution (0.4%), 
thiazolyl blue tetrazolium bromide (MTT), lactate dehydrogenase (LDH) kit, sodium 
dodecyl sulfate (SDS), dimethyl sulfoxide (DMSO), hydrochloric acid (HCl 37%), 
sodium chloride (NaCl) and potassium dihydrogen phosphate (KH2PO4) were purchased 
from Sigma-Aldrich (Germany). Ethanol was supplied by VWR. Potassium bromide 155 
(KBr) was obtained from Riedel-del-Haën (Germany). Fetal bovine serum (FBS) was 
obtained from Gibco (USA). Ultrapure water (Mili-Q Plus, Milipore Iberica, Madrid, 
Spain) was used throughout. All other chemicals were reagent grade. 
 
2.2. Cell line 160 
The Caco-2 cell line was obtained from the American Type Culture Collection 
(Rockville, USA) and used between passages 77-93. Cell cultures were grown in 75 cm2 
flasks in humidified 5% CO2/95% atmospheric air incubator at 37 ºC. Cell culture 
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medium was DMEM supplemented with 10% (v/v) FBS, 1% (v/v) L-glutamine 
solution, 1% (v/v) non-essential amino acids solution and 1% (v/v) 165 
penicillin/streptomycin. Medium was changed every 2-3 days and cells were 
subcultured weekly. 
 
2.3. Synthesis of Locust Bean Gum derivatives 
2.3.1. Purification of Locust Bean Gum 170 
LBG purification was performed as described elsewhere (Braz, Grenha, Ferreira, Rosa 
da Costa, Gamazo & Sarmento, 2017).  
 
2.3.2. Sulfation of Locust Bean Gum  
The sulfation agent, SO3
.DMF, was prepared as described before (Braz, Grenha, 175 
Ferreira, Rosa da Costa, Gamazo & Sarmento, 2017). 
 
Method 1 
LBG (500 mg) was dispersed in DMF (35 mL) and stirred at 60 ºC for 30 min, in order 
to provide the dispersion of LBG in the solvent. Then, the SO3
.DMF complex was 180 
added (9.3 mL) and the mixture reacted for 4 h under magnetic stirring. Subsequently, 
the mixture was cooled down to room temperature in an ice bath, neutralized with 30% 
NaOH solution until precipitation, and concentrated under reduced pressure at 60 ºC to 
evaporate the solvent. The residue was dissolved in distilled water (30 mL) and dialyzed 
against distilled water (5 L). The water was changed every 24 h and, after 3 days, the 185 
solution was concentrated under reduced pressure at 40 ºC. Then, ethanol was added to 
the concentrated solution, in order to precipitate the solute, and the dispersion was 
concentrated under reduced pressure at 40 ºC. The previous step was repeated twice, 
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and the last evaporation was performed until full evaporation of the solvent. The 
obtained powder was dried in a vacuum oven at 40 ºC for 3 days, affording 407 mg of 190 
brownish powder that was grinded and stored until further use. 
 
Method 2 
LBG sulfation by this method was performed as described before (Braz, Grenha, 
Ferreira, Rosa da Costa, Gamazo & Sarmento, 2017). 195 
 
2.3.3. Carboxylation of Locust Bean Gum  
LBG (500 mg) was dissolved in 200 mL of distilled water under stirring at 80 ºC for 30 
min. After cooling down, the volume was adjusted to 200 mL and the solution was 
cooled in an ice bath. Then, TEMPO (10 mg) and NaBr (50 mg) were added to the 200 
solution under stirring. A 15% sodium hypochlorite solution (3.0 mL) with pH adjusted 
to 9.3 with 2 M HCl solution, was mixed with the polymer solution. The pH was 
maintained at 9.3 by addition of a 0.05 M aqueous NaOH solution for 4 h. To stop the 
reaction, sodium borohydride (75 mg) was added and the solution was stirred for 45 
min. Then the pH of the mixture was adjusted to 8 by addition of HCl before 205 
precipitation by 2 volumes of ethanol in presence of NaCl (up to 10 g/L). The polymer 
was isolated by filtration under reduced pressure, washed several times with ethanol, 
filtered and dried in a vacuum oven at 30 ºC during 3 days. A white powder (529 mg) 
was obtained, grinded and stored until further use. 
 210 
2.3.4. Quaternary ammonium salt of Locust Bean Gum 
An aqueous solution (10 mL) of KOH (0.550 g), was prepared in a round bottom flask, 
under stirring, at 60 ºC. Then, purified LBG (506 mg) and 3.72 mL of GTMAC were 
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added. After 5 h, an equal amount of GTMAC was added to the mixture, which was 
allowed to react until the completion of 24 h. It was then diluted with 20 mL of miliQ 215 
water, allowed to cool down to room temperature, and neutralized with HCl (2M). The 
resulting solution was dialyzed for 3 days, the water being replaced every 24 h. Then, 
the LBGA solution was concentrated under reduced pressure at 40 ºC and ethanol was 
added to the concentrated solution, in order to precipitate the solute. The dispersion was 
concentrated under reduced pressure at 40 ºC and ethanol was added again and 220 
evaporated under the same conditions until full evaporation of the solvent. The obtained 
powder was dried in a vacuum oven at 40 ºC for 3 days, affording 423 mg of white 
powder that was grinded and stored until further use. 
 
2.4. Chemical characterization of Locust Bean Gum derivatives 225 
2.4.1. Fourier transform infrared (FTIR) spectroscopy 
For recording FTIR spectra of purified LBG and their derivatives, samples were 
grounded with KBr in a mortar and compressed into discs. For each spectrum, a 32-scan 
interferogram was collected in transmittance mode with a 4 cm-1 resolution in the 4,000-
400 cm-1 region. 230 
 
2.4.2. Elemental analysis 
Elemental analysis data were obtained in a Thermo Finnigan, FLASH EA 1112 Series 
(C, N, S) or in a Fisons Instruments, EA 1108 CHNS-O (O) elemental analyzer. 
 235 
2.4.3. Nuclear magnetic resonance (NMR) spectroscopy 
All liquid NMR spectra were acquired in a Bruker Avance III 400 spectrometer 
equipped with a temperature control unit and a pulse gradient unit capable of producing 
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magnetic field pulsed gradients in the z-direction of 56.0 G/cm, operating at 400.15 
MHz for hydrogen, 100.61 MHz for carbon, using a multinuclear reverse 5 mm probe 240 
(TXI). The samples where dissolved in D2O. Solid state NMR spectra were acquired in 
a Bruker Avance III 300 spectrometer equipped with a BBO probehead, operating at 
300.15 MHz for hydrogen, 75.00 MHz for carbon. The sample was spun at the magic 
angle at a frequency of 5 kHz in a 4 mm-diameter rotor at room temperature. 
1H NMR spectra were recorded with 8.22 KHz spectral window digitized with 64 K 245 
points. The 13C spectra were recorded between 0 and 238 ppm using 24,000 Hz spectral 
window digitized into 64 K points. 
Two-dimensional 1H-1H correlation spectroscopy (COSY) spectra were acquired using 
32 transients and 16 dummy scans, with a spectral width of 5000 in a total of 2K data 
points in F2 and 128 data points in F1, the relaxation delay was set to 1.5 s. 250 
Heteronuclear Single Quantum Coherence-Total Correlation Spectroscopy (1H/13C 
HSQC-TOCSY) spectra were acquired using the following parameters: 2K data points 
in F2 with a spectral width of 5000 Hz, 512 data points in F1 with a spectral width of 17 
KHz, a relaxation delay of 2 s, MLEV-17 sequence with a mixing time of 40 ms, 16 
transients and 16 dummy scans. The phase-edited heteronuclear single quantum 255 
correlation (1H/13C HSQC-DEPT) spectra were acquired in 2K data points in F2 with a 
spectral width of 5000 Hz, 512 data points in F1 with a spectral width of 17 KHz, a 
relaxation delay of 2 s, 2 to 8 transients and 16 dummy scans. The Heteronuclear 
Multiple Bond Correlation (1H/13C HMBC) spectra were acquired using the following 
parameters: 1K data points in F2 with a spectral width of 5000 Hz, 256 data points in F1 260 




The 13C MAS NMR experiments were acquired with proton cross polarization 
(CPMAS) with a contact time of 1.2 ms, and a recycle delay of 2.0 s. 
 265 
2.4.4. GPC/SEC3 analysis 
Triple detection Gel Permeation Chromatography (GPC/SEC3) analysis was performed 
in a modular system constituted by a degasser, HPLC pump (K-1001) and RI detector 
(K-2300) from Knauer, and a viscometer and RALLS from Viscotek (Trisec Dual 
Detector Model 270), using two PL aquagel-OH mixed 8 m, 300 x 7.5 mm columns. 270 
For purified LBG, LBGC and LBGS the eluent was 0.2 M NaNO3, 0.01M NaH2PO4, 
0.1% w/v NaN3, pH=7, at 1mL/min; the samples were dissolved in the eluent at 1 
mg/mL. For LBGA the eluent was 0.5 M NaNO3, 0.01M KH2PO4, 0.1% w/v NaN3, 
pH=2, at the same rate; the sample was dissolved at 1mg/mL in 10-2 M HCl. 
 275 
2.4.5. X-ray diffraction (XRD) 
Powder X‐ray diffractograms were recorded on a Panalytical X’Pert Pro diffractometer, 
operating at 45 kV and 35 mA. The patterns of the pristine and modified samples were 
recorded in the range 5‐45 degrees (2) with a step size of 0.0167 º and a time per step 
of 2 000 seconds, using CuK radiation filtered by Ni and an X’Celerator detector. 280 
Prior to the analysis, samples were reduced to a fine powder by grinding in a mortar. 
 
2.5. Production, characterization and safety evaluation of Locust Bean Gum-based 
nanoparticles 
All nanoparticles were prepared by polyelectrolyte complexation, which consists in the 285 
electrostatic interaction between the positive and negative charges of the different 




2.5.1. Production of CS/LBGS and CS/LBGC nanoparticles 
Several mass ratios of CS/LBGC and CS/LBGS (see Table 1) were used to prepare the 290 
nanoparticles by polyelectrolyte complexation. The stock solution of CS, dissolved in 
1% (w/w) acetic acid, was prepared to reach a final concentration of 1.0 mg/mL, while 
those of LBGC and LBGS, dissolved in ultrapure water, had a final concentration of 2.0 
mg/mL. Nanoparticles were prepared as described before (Braz, Grenha, Ferreira, Rosa 
da Costa, Gamazo & Sarmento, 2017). 295 
 
2.5.2. Production of LBGA/LBGS nanoparticles 
Three mass ratios of LBGA/LBGS (2/1, 1/1 and 1/2) were used to prepare the 
nanoparticles by polyelectrolyte complexation. The stock solutions of LBGA and LBGS 
were prepared by dissolving the polymers in ultrapure water, at final concentrations of 300 
0.5 mg/mL and 1.0 mg/mL, respectively. Nanoparticles were prepared as described 
before (Braz, Grenha, Ferreira, Rosa da Costa, Gamazo & Sarmento, 2017). 
 
2.5.3. Characterization of Locust Bean Gum-based nanoparticles 
2.5.3.1. Size, polydispersion index, ζ potential and production yield 305 
The size, ζ potential, polydispersion index (PdI) and production yield were determined 
as described before (Braz, Grenha, Ferreira, Rosa da Costa, Gamazo & Sarmento, 
2017).  
 
2.5.3.2. Morphological analysis 310 
The morphological examination of LBGA/LBGS nanoparticles was conducted by 
transmission electron microscopy (TEM; JEM-1011, JEOL, Japan). The samples were 
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stained with 2% (w/v) phosphotungstic acid and placed on copper grids with carbon 
films (Ted Pella, USA) for TEM observation. 
 315 
2.5.4. Safety evaluation 
The in vitro cell viability and cytotoxicity of bulk LBG, purified LBG and the 
synthesized derivatives was assessed in Caco-2 cells by the MTT and the LDH release 
assays, respectively. LBGA/LBGS nanoparticles were evaluated using the MTT assay. 
The assays were performed as described before (Braz, Grenha, Ferreira, Rosa da Costa, 320 
Gamazo & Sarmento, 2017).  
 
2.6. Statistical analyses 
The t-test and the one-way analysis of variance (ANOVA) with the pair wise multiple 
comparison procedures (Holm-Sidak method) were performed to compare two or 325 
multiple groups, respectively. All analyses were run using the SigmaStat statistical 
program (Version 3.5, SyStat, USA) and differences were considered to be significant at 
a level of P < 0.05. 
 
3. Results and discussion 330 
3.1. Synthesis and chemical characterization of Locust Bean Gum derivatives 
The syntheses of the three charged LBG derivatives were made by adapting procedures 
described in the literature for the modification of other polysaccharides. To perform the 
sulfation reaction, SO3DMF was chosen as sulfating agent (Yuan et al., 2005), as it 
presents advantages over methods involving the manipulation of either pyridine or 335 
sulfur trioxide (Alban, Schauerte & Franz, 2002; Mähner, Lechner & Nordmeier, 2001; 
Mihai, Mocanu & Carpov, 2001). For the synthesis of the sulfate derivative, two 
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approaches were performed as described in the methodology. The difference mainly 
resided in the processing of LBG prior to the addition of SO3DMF. For the introduction 
of trimethylammonium groups in LBG, GTMAC was used as alkylating agent, which 340 
proved to be efficient in the alkylation of other polysaccharides (Dionísio, Braz, Corvo, 
Lourenço, Grenha & da Costa, 2016; Qin et al., 2004; Rekha & Sharma, 2009; 
Simkovic, Yadav, Zalibera & Hicks, 2009).  
For the transformation of LBG into the corresponding polyuronic acid, TEMPO, a 
stable nitroxyl radical, was chosen as oxidizing agent (Sierakowski, Milas, Desbrières 345 
& Rinaudo, 2000). This has proved to possess a high efficiency in the conversion of 
high molecular weight polysaccharides. A highly selective oxidation of C-6 primary 
hydroxyl to carboxylic groups can be achieved in an aqueous solution of the 
polysaccharide at pH 9-11 with NaClO and catalytic amounts of TEMPO and NaBr 
(Cunha, Maciel, Sierakowski, Paula & Feitosa, 2007; da Silva Perez, Montanari & 350 
Vignon, 2003; Sierakowski, Milas, Desbrières & Rinaudo, 2000).  
As shown in Figure 2, LBG sulfate functionalization (LBGS) was confirmed by FTIR, 
through the appearance of a S=O asymmetric stretching band (Yuan et al., 2005) at 
1255 cm-1 and that of C-O-S symmetric stretching (Alban, Schauerte & Franz, 2002) at 
817 cm-1. In the carboxylate derivative (LBGC), the absorption bands at 1601 cm-1 and 355 
1415 cm-1 are attributed to asymmetric and symmetric stretching vibration of –COO-, 
respectively (Cunha, Maciel, Sierakowski, Paula & Feitosa, 2007). Since the quaternary 
ammonium groups do not display characteristic IR absorption bands (Nakanishi, Goto 
& Ohashi, 1957), evidence for formation of the amino functionalized derivative 
(LBGA) comes from the broadening of the band at 1088 cm-1 (ether C-O symmetric 360 
stretching) and the new bands at 1479 and 914 cm-1 (C-H scissoring in methyl groups of 





Figure 2 – FTIR spectra of purified Locust Bean Gum (LBG) and its ammonium 365 
(LBGA), carboxylate (LBGC) and sulfate (LBGS-M1) derivatives. 
 
In the elemental analysis, the weight percentages found for the analysed elements are 
compiled in Table S1. 
For LBGS, different degrees of substitution were obtained, even under the same 370 
reaction conditions. For the sample of LBGS obtained by method 1 (LBGS-M1), a C:S 
molar ratio of 8.78 was obtained, which corresponds to a degree of substitution (DS) of 
3.5. Therefore, if sulfate groups are assumed to be in the form of sodium salts, a 
molecular formula between C30H47S3O34Na3 and C30H46S4O37Na4, to which corresponds 
a mean molecular weight of 1166 g/mol, is derived. On the other hand, the samples of 375 
LBGS obtained by method 2 presented a high variability on C:S molar ratio, ranging 
from 26.76 in batch 1 (LBGS-M2-B1) to 6.55 in batch 2 (LBGS-M2-B2), and batch 3 
(LBGS-M2-B3) presenting a value of 10.24. These values corresponded to values of DS 
of 1.22, 4.63, and 3, and to the mean molecular weights of 932, 1282, and 1111 g/mol, 
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respectively. As indicated in materials and methods, and stated above, the difference 380 
between the two methods only refers to a preliminary treatment of LBG before the 
sulfation reaction. In the second method, a better dispersion of LBG was promoted 
before the contact with the sulfating agent in an attempt to improve the reaction. The 
need for this pre-treatment was motivated by the poor solubility of LBG in DMF. Since 
in the sulfation reaction the polymer is used as a dispersion in the solvent, it would be 385 
expected that a more effective dispersion would favour the reaction. Quite surprisingly, 
it was observed that, although the pre-treatment afforded the highest value of DS (4.63), 
it also gave the lowest substitution (1.22), while in its absence an intermediate value of 
DS was obtained. This variation in DS translates, in the FTIR spectra of the various 
samples, in different intensities of the band at 1255 cm-1 relative to other bands in the 390 
spectrum, with more substituted samples presenting a more intense band (Figure S1).  
Assuming that better dispersion of LBG leads to higher reaction efficiency and affords 
higher values of DS, it seems that the dispersibility of LBG in the reaction medium does 
not directly correlate to the method used in its dispersion. One reason for the observed 
variability in DS may be the fact that, contrary to what is observed in the reactions 395 
described below (oxidation and alkylation), in which LBG progressively dissolves as 
the reactions proceed, in this case a total solubilisation is never reached. This renders 
the outcome of this reaction quite unpredictable and, therefore, this issue will have to be 
tackled in future work. In fact, the reaction of LBG activated by pre-soaking in DMF 
and dispersed in the same solvent, with solid SO3DMF complex, bellow 15 ºC, led to a 400 
DS of approximately 4 (Maiti, Chowdhury, Chakraborty, Ray & Sa, 2014). On the other 
hand, sulfation of LBG dispersed in formamide with SO3pyridine complex, under 
diverse conditions of reaction time, temperature, and amount of sulfating agent, led to 
DS varying between approximately 2 and nearly 5 (Wang et al., 2014). Again, the 
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soaking of LBG with the solvent prior to the reaction led to an intermediate DS relative 405 
to the range obtained without any pre-treatment, although in the latter case a different 
reagent and solvent were used. Nevertheless, only one batch per reaction conditions 
seems to have been obtained in both these works and, therefore, the state of dispersion 
of LBG in each case may well be the factor governing the substitution obtained, instead 
of the parameters analysed. Moreover, in the latter work, no correlation or trend 410 
between molecular weights of the obtained derivatives or depolymerization of the 
parent polysaccharide and degree of substitution is observed. On the contrary, a very 
erratic dispersion of molecular weights with growing DS is obtained, pointing to a 
random behaviour in this reaction.  
For LBGC, a C:O ratio of 1.02 was found, which corresponds to a degree of oxidation 415 
(DO) of 4, meaning that all the free C-6 must have been oxidized. Assuming all 
carboxylate groups to be in the sodium salt form, the molecular formula would be 
C30H38O29Na4, and the molecular weight 955 g/mol. This value is not surprising, in 
view of the effectiveness of the oxidizing system, although somewhat higher than DO 
values observed for other galactomannans, which typically lay below 70% of the free 420 
units (Cunha, Maciel, Sierakowski, Paula & Feitosa, 2007).  
In LBGA, the C:N molar ratio was found to be 13.16, corresponding to a DS of 4.24. If 
all the ammonium groups are in the form of chloride salt, this corresponds to a 
molecular formula between C54H106O29N4Cl4 and C60H120O30N5Cl5, and the mean 
molecular weight of 1454 g/mol. This corresponds to a full reaction of the free C-6 425 
hydroxyl groups, along with reaction on some secondary hydroxyls, in line with what 
was observed by us in a similar modification performed in pullulan (Dionísio, Braz, 
Corvo, Lourenço, Grenha & da Costa). 
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The analysis of the 1H NMR and 13C spectra of LBG and the obtained derivatives 
(Figure S2) allowed us to obtain a molecular view on the success of the 430 
transformations. However, the broadened signals in the 1H spectra do not allow the 
evaluation of the derivatization locations and, therefore, spectral assignment was 
performed through 2D NMR (1H,1H-COSY and 13C,1H-HSQC-DEPT) experiments.  
Figure 3 shows the 1H/13C HSQC-DEPT NMR spectra of untreated LBG (a), LBGS-
M2-B1 (b), LBGC (c), and LBGA (d). In untreated LBG, the two anomeric carbons C-1 435 
from mannose and galactose residues resonate at 102.8 and 100.3 ppm, respectively. 





Figure 3 – 1H/13C HSQC-DEPT spectra of (a) LBG, (b)LBGS-M2-B1, (c) LBGC, and 440 
(d) LBGA; (*) Assignments attributed to the sulfate derivative. 
 
The attachment of sulfate groups to the hydroxyls results usually in downfield shifts of 
the carbons bearing the sulfates and the protons linked to them (Duus, Gotfredsen & 
Bock, 2000). LBG primary hydroxyl groups in C-6 position are clearly the most 445 
reactive towards the sulfation reaction, as would be expected. In LBGS (Figure 3-b), 
the C-6 resonances exhibit a downfield shift to 66.4 ppm, indicative of C-6 sulfation. It 
is also noticeable a sulfate introduction in position C-3. The lower steric hindrance in 
the branched galactose residues in comparison to the main chain mannose leads to the 
assumption that sulfate introduction would have taken place preferentially in the 450 
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hydroxilated positions of the former, and as such 3-Gal would have been preferentially 
substituted (Muschin et al., 2016). The carboxylation of LBG imposes a different effect 
on the 1H/13C HSQC-DEPT spectra, since the resonances of the positions that indeed 
react are expected to disapeer from the original location. From Figure 3-c it is possible 
to observe that C-6 resonance is almost absent, which means that once again this was 455 
the reaction location. Unreacted positions C-2,C-3 and C-4 appear unchanged, while  
additional resonances appear downshifted from the original envelope of resonances, 
most likely due to oxidized C-6 positions. The carboxylation is also confirmed by the 
presence of the carbonyl in the 13C NMR spectra at 175.3 ppm (Figure S2-f). The 
attachment of N-(2-hydroxypropyl)-N,N,N-trimethylammonium to LBG produces a 460 
derivative with a high swelling capability. Here, the introduction of the ammonium 
group is confirmed by the well resolved N-methyl resonances at 3.146 ppm. However, 
these resonances dominate the whole spectrum (Figure 3-d) and all 1H signals are very 
broadned. As such, this sample was analysed in the solid state (Figure S2-e), where the 
resonances of the ammonium group at 54.62 ppm, the anomeric carbons (102.17 and 465 
100.71 ppm) and the remaining polysaccharide chain between 90 and 60 ppm could be 
detected. 
The average molecular weights, polydispersity index (PdI), and radius of gyration (Rg) 
of LBG and its derivatives are presented in Table S2. For the parent polysaccharide 
(LBG), these are in general agreement with the literature (Dakia, Blecker, Robert, 470 
Whatelet & Paquot, 2008; Kawamura, 2008). Upon chemical modification, an increase 
in both molecular weight and Rg was observed in LBGA, and a big decrease in these 
parameters was patent in LBGC and in the analysed sample of LBGS-M1. The increase 
identified in LBGA is attributable to the presence of the introduced pendant chains, 
which led to an increase in the molar mass of the repeating unit and force the polymer, 475 
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once in solution, and similarly to what happens in the crystalline state (XRD results), to 
adopt a conformation that is suitable to accommodate such bulky groups. The results 
observed in the LBGC and LBGS-M1 derivatives suggest the occurrence of 
depolymerization during the chemical modification, a common observation when the 
conditions of either the oxidation (Cunha, Maciel, Sierakowski, Paula & Feitosa, 2007) 480 
or the sulfation reaction (Alban, Schauerte & Franz, 2002) are applied. The latter was 
already stated in a similar modification performed in pullulan (Dionísio, Braz, Corvo, 
Lourenço, Grenha & da Costa). Moreover, at least in the analysed sample, and as 
verified in the referred sulfation of pullulan, no additional dehydration reactions, with 
intra- and/or intermolecular crosslinking leading to a fraction of high molecular weight 485 
chains, observed in sulfation reactions carried out at higher temperatures (Mihai, 
Mocanu & Carpov, 2001), occurred in this case.  
Figure 4 shows the XRD patterns of the pristine and modified LBG samples. The 
pattern of LBG, with a broad peak centered at ca. 20º 2 with shoulders at ca. 7.5 and 
15º 2 reflects the predominantly amorphous nature of the material. These shoulders 490 
vanish in the pattern of LBG modified with sulfate (LBGS-M2-B2), probably due to 
some changes in the organization of the polymer chains imposed by the sulfate groups. 
In what concerns the ammonium derivative, the pattern clearly shows an increase of 
intensity for higher d-spacings, which is compatible with an increase of the distance 
between the polymer chains, due to the long chain bearing the ammonium group 495 
(Dionísio, Braz, Corvo, Lourenço, Grenha & da Costa). When compared with the other 
modifications, the introduction of carboxylate groups gives rise to the highest degree of 
disruption of the long-range order of the LBG polymer chains. The intensity of the peak 
that appears at 20º 2 in the pattern of the original polymer (LBG) is substantially 
reduced and new broad peaks are now present at ca. 12 and 25º 2This is not 500 
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surprising, as the conversion of galactose and mannose units into the corresponding 
uronic acids would enormously affect the conformation of the polysaccharide chains 
and, consequently, the way they pack in the solid phase. 

 505 
Figure 4 – XRD patterns of (a) pristine locust bean gum (LBG), (b) LBGS-M2-B2, (c) 
LBGA, and (d) LBGC. 
 
3.2. Characterization of nanoparticles 
The production of LBG derivatives described above endowed the polymer with charged 510 
groups, enabling the preparation of nanoparticles by polyelectrolyte complexation. This 
is a mild method occurring in hydrophilic medium, devoid of aggressive conditions 
such as organic solvents or high shear forces, and involving electrostatic interactions 
between oppositely charged polymers (Grenha, 2012; Prego, Torres & Alonso, 2005). 
Three derivatives were synthesized which were used in the production of different 515 
formulations of nanoparticles. The negatively charged sulfate and carboxylate 
derivatives were complexed with chitosan to produce CS/LBGS and CS/LBGC 








nanoparticles, respectively. In turn, the ammonium derivative was complexed with the 
sulfate derivative in the innovative approach of producing LBG-only nanoparticles 
(LBGA/LBGS). The results regarding the physicochemical characterization of the 520 
referred nanoparticle formulations are displayed and discussed below. 
 
3.2.1. CS/LBGS and CS/LBGC nanoparticles 
The first approach towards the formulation of CS/LBGS and CS/LBGC nanoparticles 
involved the production of carriers having higher or at least the same amount of LBG 525 
derivative comparing to chitosan. In this regard, the starting mass ratios selected for the 
production of the referred formulations of nanoparticles were 1:1, 1:1.5 and 1:2. In the 
course of the experiments, the need to test other ratios was identified, not necessarily 
being coincident for each formulation, thus justifying the slight differences observed 
between the two formulations. 530 
Table 1 displays the physicochemical characteristics of CS/LBGS nanoparticles. For 
the production of these nanoparticles, LBGS corresponding to method 1 was used. With 
CS/LBGS mass ratios varying between 1:1 and 1:2.5, and recalling that CS amount 
remains constant in all formulations, it was verified that nanoparticle size generally 
increased with increasing amounts of LBGS. The minimum size was 364 nm (CS/LBGS 535 







Table 1 - Physicochemical characteristics and production yield of CS/LBGS, CS/LBGC 
and LBGA/LBGS unloaded nanoparticles (mean ± SD; n ≥ 3). Different letters 
represent significant differences in each parameter and formulation (P < 0.05). 









1:1 364.1 ± 30.0 a 0.34 ± 0.09 +45.6 ± 1.2 d 37.3 ± 5.6 h 
1:1.25 403.7 ± 37.7 ab 0.40 ± 0.06 +40.0 ± 0.8 e 58.1 ± 2.7 i 
1:1.5 pp* 1.0 ± 0.0 -5.9 ± 4.4 f n.d. 
1:2 500.3 ± 59.6 bc 0.47 ± 0.08 -23.9 ± 2.7 g 56.6 ± 7.2 i 
1:2.5 589.0 ± 69.5 c 0.54 ± 0.03 -28.5 ± 5.0 g n.d. 
CS/LBGC 
1:0.75 489.9 ± 63.6 a 0.45 ± 0.04 +45.5 ± 13.0 b 49.0 ± 5.0 d 
1:1 479.1 ± 30.8 a 0.51 ± 0.07 +42.2 ± 7.4 b 54.3 ± 7.0 d 
1:1.25 828.8 ± 299.8 a 0.64 ± 0.15 +28.8 ± 7.3 b n.d. 
1:1.5 pp* 1.0 ± 0.0 -2.5 ± 8.3 c n.d. 
1:2 pp* 1.0 ± 0.0 -15.2 ± 7.4 c n.d. 
LBGA/LBGS 
1:2 206.6 ± 5.0 a 0.13 ± 0.03 -27.8 ± 1.4 c 30.0 ± 8.6 e 
1:1 pp - - - 
2:1 368.3 ± 19.3 b 0.38 ± 0.05 +48.1 ± 1.5 d 16.7 ± 3.8 f 
 
n.d.: not determined; pp: precipitate; *slight precipitation compromised the measurement of this parameter 545 
 
The registered increase in size as higher amount of LBGS is included in the 
formulations as compared with CS, might be explained by the increase of total mass of 
polymers that is present. This effect was also reported in other works using the same 
nanoparticle production method (Grenha et al., 2010; Rodrigues, da Costa & Grenha, 550 
2012). Precipitation was found to occur for an intermediate formulation (CS/LBGS = 
1:1.5, w/w), being coincident with a zeta potential close to zero (-5.9 mV) that possibly 
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is not sufficient to provide particle repulsion, thus leading to aggregation. A clear 
Tyndall effect was observed in all the other nanoparticle formulations. The formulations 
1:1 and 1:1.25 (w/w) exhibited a strong positive zeta potential of more than +40 mV. 555 
The incorporation of a higher amount of LBGS, from formulation 1:1 to 1:1.25 (w/w) 
resulted in a corresponding decrease in the zeta potential from +46 mV to +40 mV (P < 
0.05). The formulations 1:2 and 1:2.5 (w/w) presented a complete shift in the zeta 
potential as the nanoparticles became negatively charged, with zeta potential reaching -
29 mV. Again, the incorporation of a higher amount of LBGS led to a nominal decrease 560 
in the zeta potential, although this is not statistically significant. This absolute shift of 
nanoparticle charge reflects the higher amount of LBGS that is present in the 
nanoparticles, but also demonstrates that both polymers have different charge density. 
Zeta potential results are perfectly in line with the charge ratios that were calculated for 
each formulation of nanoparticles, as is depicted in Figure 5-a. This figure shows the 565 
effect of charge ratios on the zeta potential of CS/LBGS nanoparticles prepared with 







Figure 5 – Effect of charge ratio (-/+) on the zeta potential of (a) CS/LBGS 
nanoparticles and (b) CS/LBGC nanoparticles. 
 
For each polymer, by dividing the charge of the repeating unit by its molar mass, a 575 
charge per mass ratio may be obtained. CS has higher charge per mass ratio than LBGS 
(4.72 x 10-3 vs 3.00 x 10-3 charges/g, respectively), which justifies why formulations 
CS/LBGS = 1:1 and 1:1.25 (w/w) have a -/+ charge ratio below 1. The strong positive 
zeta potential (> +40 mV) of these nanoparticles is due to the predominance of positive 






















































coincident with a charge ratio around 1, justifying that the determined zeta potential was 
close to neutrality. In fact, although a 1:1 -/+ charge stoichiometry might not imply the 
occurrence of complete charge neutralization, due to steric limitations and different 
charge spacing in the intervenient species (Rodrigues, da Costa & Grenha, 2012), one 
may assume a preferential interaction between the sulfate and the ammonium groups, 585 
both weakly hydrated, instead of with the strongly hydrated counterions (Crouzier & 
Picart, 2009). This mainly leads to an intrinsic charge match in detriment of an extrinsic 
charge compensation and, thus, to a small deviation from neutrality. Finally, the 
continued addition of the negative polymer (formulations CS/LBGS = 1:2 and 1:2.5, 
w/w) produced an excess of negative charges, resulting in -/+ charge ratio above 1 and, 590 
consequently, negatively charged nanoparticles. A similar behavior concerning the 
charge ratios leading to either precipitation or formation of nanoparticles, was 
previously described (Rodrigues, da Costa & Grenha, 2012). 
The polydispersity index varied between 0.3 and 0.5, which is considered high. 
Regarding the production yield, very reasonable values for this nanoparticle production 595 
methodology, were obtained. A yield of 37% was registered for formulation 1:1 (w/w) 
which increased to 58% (P < 0.05) for formulation 1:1.25 (w/w). This is a result of the 
proper mechanism of nanoparticle formation, based on the neutralization of chitosan 
amino groups by the sulfate groups of LBGS. The incorporation of a higher amount of 
LBGS provides an additional amount of sulfate groups that interacted with chitosan, 600 
thus forming a higher amount of nanoparticles (Fernández-Urrusuno, Romani, Calvo, 
Vila-Jato & Alonso, 1999). However, this effect occurs up to a certain limit. As 
observed, further increasing the amount of LBGS led to precipitation, certainly because 
of the demonstrated neutralization of charges, as referred above. On keeping increasing 
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LBGS mass, nanoparticles are again formed (CS/LBGS 1:2 and 1:2.5, w/w), this time 605 
with an opposite charge and a high yield (57% for formulation 1:2, w/w). 
The results obtained for CS/LBGC nanoparticles were rather different comparing to 
those described above regarding CS/LBGS formulations. In this case, as shown in 
Table 1, the initially approached formulation of CS/LBGC 1:1 (w/w) resulted in a size 
of 479 nm, which is more than 30% higher than the corresponding CS/LBGS 610 
formulation (P < 0.05). The formulation 1:1.5 (w/w) already presented precipitation, 
similarly to 1:2 (w/w) and, therefore, the intermediate formulation 1:1.25 (w/w) was 
produced. 
The registered size revealed a strong increase to 829 nm, although this is not statistically 
significant as is accompanied by an extremely high standard deviation, which indicates 615 
reproducibility issues. This formulation also presented a high polydispersity index and, 
thus, was not characterized for production yield. An attempt was also performed to 
produce nanoparticles at CS/LBGC ratio of 1:0.75 (w/w), but the characteristics were 
very similar, under all aspects, to those of ratio 1:1 (w/w). The polydispersity index was 
around 0.5 – 0.6, which is even higher than those registered for CS/LBGS nanoparticles, 620 
reinforcing the difficulty in producing suitable nanoparticles with the LBGC derivative. 
The zeta potentials were highly positive (around +45 mV), which probably contributes 
to the system stability. The determination of the charge ratios involved in each 
formulation of nanoparticles is depicted in Figure 5-b. 
As observed, formulations 1:0.75 and 1:1 (w/w) have a -/+ charge ratio between 0.5 and 625 
0.7 which does not translate into significant differences in the zeta potential. 
Nanoparticles 1:1.25 (w/w) displayed a -/+ charge ratio of 0.85 which induced a 
nominal decrease of the zeta potential to +29 mV, although not to a statistically 
significant level. As observed above for CS/LBGS nanoparticles, reaching a -/+ charge 
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ratio around 1 (formulation 1:1.5, w/w) resulted in precipitation. However, in this case 630 
the continued addition of the negative polymer to formulate CS/LBGC = 1:2 (w/w) 
nanoparticles still resulted in precipitation, despite the -/+ charge ratio of 1.4. It is 
important to highlight that, while the resulting zeta potential for this formulation was of 
-15 mV, in the CS/LBGS corresponding formulation was -24 mV, which possibly 
permitted enough repulsion to stabilize the formed nanoparticles.  635 
The determined production yields were satisfactory for this methodology, as referred 
above, being around 50%. When comparing the zeta potentials of these nanoparticles 
with those obtained for CS/LBGS nanoparticles (Table 1), a similar trend was 
observed. In this regard, increasing the amount of LBGC present in the formulation 
reflected in a decrease of the surface charge, owing to the higher amount of negative 640 
groups being incorporated. Similarly to CS/LBGS nanoparticles, the formulation 1:1.5 
was the one showing neutrality (zeta potential of -2.5 mV) and the further incorporation 
of LBGC led to a decrease in the surface charge. The precipitation verified for the latter 
was possibly due to the fact that the existing surface charges were not sufficient to 
ensure particle repulsion. The resemblance of the trend, particularly regarding the shift 645 
of the zeta potential (occurring for mass ratio of 1:1.5), suggests the similarity of charge 
density in both derivatives. In fact, LBGS has a charge per mass ratio of 3.00 x 10-3 
charges/g, as stated before, and LBGC has 3.14 x 10-3 charges/g. 
 
3.2.2. LBGA/LBGS nanoparticles 650 
One of the great novelties of producing LBG charged derivatives was the possibility of 
using these to produce, for the first time, LBG-only nanoparticles. Given the difficulties 
in producing nanoparticles with the LBGC derivative, as stated above, it was decided to 
produce the LBG-only nanoparticles using just LBGS as negative counterpart. The 
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nanoparticles were produced by complexation of this derivative (method 2 – 50/50 655 
mixtures of batches 2 and 3) with the ammonium derivative (LBGA) by the same 
methodology reported in the other cases (polyelectrolyte complexation). 
After observing the precipitation of the formulation LBGA/LBGS 1:1 (w/w), possibly 
resulting from a (-/+) charge ratio of 1.09, formulations 1:2 (w/w) and 2:1 (w/w) were 
developed, which results are depicted in Table 1. 660 
The formulation containing the highest amount of LBGS registered size of 207 nm and 
low polydispersity index of 0.13. Naturally, the zeta potential was negative (-28 mV), 
reflecting the higher content of negatively charged derivative, which translated into a (-
/+) charge ratio of 2.17. As expected, the formulation having more LBGA exhibited a 
strongly positive zeta potential (+48 mV; P < 0.05), as a result of the (-/+) charge ratio 665 
of 0.54. However, this particular formulation presented higher size (368 nm) along with 
higher polydispersity index (P < 0.05). At a first evaluation, the size differences could 
be considered unexpected. In fact, for the preparation of these nanoparticles, LBGA is 
kept constant at 0.5 mg/mL and LBGS concentration is adapted to meet the desired 
ratio. Therefore, formulation 1:2 (w/w) accounts with a total polymeric mass of 1.5 mg, 670 
while formulation 2:1 (w/w) accounts with 0.75 mg. In line with this, formulation 1:2 
(w/w) was perhaps expected to have larger size. However, if one considers the 
molecular weight of the derivatives, reported in section 3.3.1, LBGA has much higher 
Mn than LBGS (500 600 vs 21 380). In this regard, it becomes justifiable that 
nanoparticles having double amount of LBGA comparing with LBGS are those 675 
displaying the highest size. 
Regarding the production yield, this was very different between the two formulations. 
While formulation 1:2 (w/w) resulted in 30%, formulation 2:1 (w/w) presented 17% (P 
< 0.05). This difference is probably due to variances in the molecular weight of the two 
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derivatives. In formulation 1:2 (w/w), there is a determined amount of a high molecular 680 
weight polymeric chain and a double amount of a shorter macromolecule that possibly 
presents higher diffusion. On the contrary, in formulation 2:1 (w/w) the amount of the 
polymer with higher molecular weight is double comparing with that of the smaller 
polymer, thus resulting in a lower number of interactions and limiting the amount of 
nanoparticles formed. 685 
LBG-only nanoparticles were morphologically characterized by TEM and the specific 
formulation LBGA/LBGS 1:2 (w/w) was considered representative for this end. As 
shown in Figure 6, nanoparticles present a spherical shape and have compact structure. 
 
Figure 6 – TEM microphotograph of LBGA/LBGS = 1:2 (w/w) nanoparticles. 690 
 
3.3. Safety evaluation 
Caco-2 cells were used to evaluate the toxicological profile of LBG and the synthesized 
derivatives. Cell viability was determined after exposure to the mentioned materials at 
different concentrations, for a period of 3 h (Figure S3) and 24 h (Figure 7). Cell 695 
viability values were calculated in relation to the 100% cell viability considered for the 
incubation with DMEM (negative control of cell death). The evaluation of LBG-based 
samples generally evidenced a mild effect on cell viability, considered to be devoid of 
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biological relevance. In fact, with the exception of LBGA, all the other samples resulted 
in viabilities above 70% after 3 h or 24 h of exposure, when tested at concentrations 700 
varying within 0.1 and 1.0 mg/mL. While at 3 h values remained above 88% in all 
conditions, the prolonged exposure until 24 h induced slight alterations. However, these 
were in most cases devoid of physiological relevance and the only remarkable effect 
resides in the decrease of the viability induced by the contact with LBGC at the highest 
concentration tested (1.0 mg/mL) (P < 0.05) to a value around 70%. Importantly, this is 705 
the value considered by ISO 10993-5 (ISO, 2009) as the level below which a toxic 
effect is assumed to occur. 
 
 
Figure 7 – Caco-2 cell viability measured by the MTT assay after 24 h exposure to 710 
increasing concentrations of bulk Locust Bean Gum, purified Locust Bean Gum (LBG) 
and its ammonium (LBGA), carboxylate (LBGC) and sulfate (LBGS) derivatives; and 
LBGA/LBGS nanoparticles (NP). Data represent mean ± SEM (n ≥ 3, six replicates per 
experiment at each concentration). Dashed line indicates 70%. * P < 0.05 compared 
with DMEM. 715 
 
Although not directly proposed herein as matrix material per se, unmodified LBG was 
also tested, because its application in drug delivery has been reported, in many 
occasions addressing oral delivery strategies (Colombo et al., 1990; Conte & Maggi, 





























Jana, Gandhi, Sheet & Sen, 2015; Malik, Arora & Singh, 2011a; Malik, Arora & Singh, 
2011b; Ngwuluka, Choonara, Kumar, du Toit, Modi & Pillay, 2015; Sandolo, Coviello, 
Matricardi & Alhaique, 2007; Sujja-areevath, Munday, Cox & Khan, 1998; Syed, 
Mangamoori & Rao, 2010; Tobyn, Staniforth, Baichwal & McCall, 1996), but data on 
its effect on epithelial cells are not available in the literature. Moreover, a comparison 725 
between bulk LBG and purified LBG was performed, revealing no significant 
differences, which indicates an absence of effect of the purification process in the 
cytotoxic profile of the material. It is important to mention that the results shown for 
LBGS sample correspond to the derivative obtained by the second method of synthesis 
(method 2 – batch 1), which were similar to those registered for the derivative obtained 730 
in the first method (method 1; data not shown). 
As mentioned before, LBGA is the material that presents the most distinct behavior, 
appearing as the exception to the mild effect observed for the tested materials. In fact, a 
strong decrease of cell viability to approximately 30% was obtained for all the tested 
concentrations even upon 3 h exposure (Figure S3). The effect was even more drastic 735 
after 24 h (Figure 7), when a very low level of cell survival was registered (P < 0.05). 
Regarding concentration, there are no evidences of statistically significant 
concentration-dependent effect. The influence of surface charge on cytotoxicity remains 
largely unresolved and sometimes the literature reports contradictory results. This is 
possibly due to different characteristics of basic materials being used and also to 740 
dissimilar assay conditions, which are frequently not described in sufficient detail. 
Nevertheless, there are many indications suggesting that surface charge has a role on 
cellular uptake (Fröhlich, 2012; Zhao, Zhao, Liu, Chang, Chen & Zhao, 2011) and on 
the toxicological effect of substances. In this context, positively charged materials have 
been frequently found to be more cytotoxic than neutral or negatively charged 745 
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counterparts, because positive charges provide a means for stronger interaction with cell 
surfaces, in many cases associated with internalization of the material (Bhattacharjee et 
al., 2010; Fröhlich, 2012; Ilinskaya, Dreyer, Mitkevich, Shaw, Pace & Makarov, 2002; 
Platel, Carpentier, Becart, Mordacq, Betbeder & Nesslany, 2016; Turcotte, Lavis & 
Raines, 2009). These statements are coincident with the results of our work, since the 750 
neutral (bulk LBG and LBG) and negatively charged materials (LBGC and LBGS) were 
devoid of toxicity. Another parameter that could be indicated as playing a significant 
role on toxicity consists on the molecular weight of the polymers. In this regard, 
although it could be suggested that smaller sizes have higher probability to be 
internalized by the cells, the literature has been reporting no correlation (Huang, Khor & 755 
Lim, 2004). In this work, the molecular weight of the polymers also seems to not be 
driving the cytotoxic behaviour, as LBGS is the smallest molecule and shows no toxic 
effect. 
Comparing to LBGA, a very similar toxicological profile was observed for an 
ammonium derivative of another polysaccharide, pullulan, which was synthesized using 760 
the same methodology (Dionísio, Braz, Corvo, Lourenço, Grenha & da Costa, 2016; 
Dionísio, Cordeiro, Remuñán-López, Seijo, Rosa da Costa & Grenha, 2013). In that 
case, the assessment was performed in Calu-3 cells (bronchial cell line) and cell 
viabilities around 50-60% were observed after 3 h, decreasing to 40% at 24 h. Although 
a time-dependent effect is also clearly observed, the effect on cell viability is not as 765 
strong as for LBGA. The first consideration to take into account is the fact that the 
assessment was performed in different cell lines, which may translate into different 
sensitivity. Additionally, different charge density of the polymers might be indicated as 
possible justification. In this regard, LBGA has a DS of 4.24, while the corresponding 
pullulan derivative (ammonium pullulan) has a DS of 2 (Dionísio, Braz, Corvo, 770 
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Lourenço, Grenha & da Costa). A higher number of positive charges results in stronger 
interactions and, thus, in lower cell viability. Complementing this idea, a work reporting 
the cytotoxic effect of cationic pullulan microparticles on human leukemic K562(S) 
cells, has established that toxicity increased with the increase molar concentration of 
amino groups (Constantin, Fundueanu, Cortesi, Esposito & Nastruzzi, 2003). In the 775 
work reporting the cytotoxic evaluation of pullulan derivatives, a sulfate derivative of 
that polysaccharide was also assessed. Similarly to what was observed for LBGS, the 
registered cell viability was well above 80% (Dionísio, Cordeiro, Remuñán-López, 
Seijo, Rosa da Costa & Grenha, 2013). 
Considering that polymer samples were solubilized in water and diluted with cell 780 
culture medium prior to incubation with the cells, an additional control was performed 
consisting in a mixture of DMEM and H2O in the same ratio used for the samples. This 
enables a real evaluation of the contribution of the polymers to the final cell viability. 
The cell viability induced by this control varied between 72% and 80%. Upon 3 h of 
contact there is a statistically significant difference between the control (DMEM + H2O) 785 
and all samples, but with LBGS (Figure S3). In fact, higher cell viability is observed 
upon exposure to bulk LBG, LBG and LBGC, suggesting a positive effect of the 
presence of the polymers. Interestingly, after 24 h exposure, a shift is observed in the 
effect induced by LBGC and LBGS (Figure 7). In the former, the prolonged contact 
with the cells at the two highest concentrations reverts the positive effect on cell 790 
viability observed at 3 h. For LBGS, the results demonstrate that at the two lowest 
concentrations, the more prolonged contact improves cell viability, which was not 
registered at 3 h. 
One of the most important information provided by the evaluation performed with the 
MTT assay, is that only the more prolonged exposure to the highest concentration tested 795 
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(1.0 mg/mL; 24 h) induced a relevant decrease of Caco-2 cell viability (exception for 
LBGA). Therefore, it was deemed important to complement the results at these 
conditions by means of the quantification of the amount of LDH released by Caco-2 
cells. To perform this assay, DMEM was used as negative control of LDH release and a 
lysis buffer was used as positive control. Thus, the negative control (DMEM) 800 
corresponds to a normal cell death, while the positive control (lysis buffer) represents 
100% cell death. 
The results of LDH release after 24 h exposure to the materials at the concentration of 
1.0 mg/mL (Figure S4) showed no statistically significant differences between the 
negative control (DMEM), bulk LBG, LBG, LBGC and LBGS. This means that these 805 
materials do not compromise Caco-2 cell membrane integrity, as LDH release was not 
increased when compared with that observed upon incubation with cell culture medium 
(DMEM). On the contrary, the contact with LBGA resulted in 90% LDH release, which 
is considered comparable to that induced by the lysis buffer, thus indicating a high 
cytotoxic effect that results in cell membrane disruption. The results obtained in this 810 
assay reinforce those found in the MTT tests, confirming the high cytotoxicity of 
LBGA. 
Overall, the results obtained with these complementary cytotoxicity assays indicate that, 
with the exception of LBGA, LBG and negatively charged derivatives, present no 
cytotoxicity towards this in vitro intestinal model. This was observed even for the 815 
highest concentration tested (1.0 mg/mL) and for prolonged contact (24 h), suggesting 
their relative safety for an application as matrix materials of oral drug delivery systems.  
Complementarily, the effect on cell viability provided by LBGS (method 2 – batch 1) 
was assessed in Calu-3 and A549 cells (respiratory epithelial cells) and the results are in 
line with those observed for Caco-2 cells (Figures S5 and S6). 820 
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Proposing materials for drug delivery applications requires testing the developed 
carriers and not only assume the apparent absence of cytotoxicity of the polymers. In 
this regard, it is consensual that carriers exhibit new and unique properties, thus 
generating potential different risks as compared to the raw materials of the same 
chemistry (Aillon, Xie, El-Gendy, Berkland & Forrest, 2009), as observed in other 825 
works (Dionísio, Braz, Corvo, Lourenço, Grenha & da Costa, 2016; Dionísio, Cordeiro, 
Remuñán-López, Seijo, Rosa da Costa & Grenha, 2013). In this regard, in addition to 
the evaluation of the polymer and the synthesized derivatives, a preliminary evaluation 
of LBG-based nanoparticles was further performed using the MTT assay. Although 
several formulations were proposed and developed herein, that corresponding to LBG-830 
only nanoparticles was selected for this step due to the novelty of the polymer in 
nanoparticle production. 
The viability of Caco-2 cells upon exposure to LBGA/LBGS nanoparticles is shown in 
Figure S7 (3 h) and Figure 7 (24 h). The two formulations LBGA/LBGS 2:1 and 1:2 
(w/w) were assessed. For formulation 2:1 (w/w) the comparison of results obtained for 835 
each tested time revealed a statistically significant difference between concentrations 
0.1 and 1.0 mg/mL (P < 0.05). Formulation 1:2 (w/w) did not evidence significant 
differences between all concentrations at the two tested times. A similar observation 
was made after comparing the same concentrations for different times (3 h and 24 h). 
The most remarkable result is that no significant effect on cell viability is observed for 840 
both formulations at all concentrations, up to 24 h. Actually, the registered viability was 
over 80% in all cases, which, as said before, is considered very acceptable according to 
the ISO10993-5 (ISO, 2009). 
Curiously, the exposure of the cells to the formulation LBGA/LBGS 2:1 (w/w) resulted 
in an increase of cell viability with the increase of nanoparticle concentration at 3 h and 845 
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24 h (P < 0.05). This was unexpected and may be due to the fact that LBG is a 
polysaccharide with capacity to promote cell proliferation in some cell lines, as reported 
in the literature (Perestrelo, Grenha, Rosa da Costa & Belo, 2014). Despite the 
formulation LBGA/LBGS 2:1 (w/w) could improve cell proliferation with increasing 
concentrations, formulation LBGA/LBGS 1:2 (w/w), generally induced constant cell 850 
viability near 100%, irrespective of the concentration. 
Comparing with the control (DMEM + H2O) it is observed that the nanoparticles 
generally elicit higher cell viability, varying between 82% and 100% (P < 0.05). The 
most remarkable observation in the whole set of cell viability assessment is that, in spite 
of the strong decrease in cell viability induced by the contact with LBGA, this effect 855 
was completely reverted when the cells were exposed to a nanoparticulate form of the 
derivative. This was also observed in works using an ammonium derivative of pullulan, 
in which the derivative elicited around 40% cell viability upon 24 h of exposure, while 
nanoparticles produced with the polymer registered increased cell viabilities to values of 
70% - 80% (Dionísio, Braz, Corvo, Lourenço, Grenha & da Costa; Dionísio, Cordeiro, 860 
Remuñán-López, Seijo, Rosa da Costa & Grenha, 2013). The different impact on cell 
viability generated by LBGA in form of polymer and of nanoparticles is possibly 
explained by a differential contact of each of the materials with the cells. While the 
polymer in form of a solute is presented as an extended chain and, thus, has a higher 
surface of contact with the cells, nanoparticles have comparatively a lower contact. 865 
Additionally, the number of positive charges available for interaction with the 
negatively charged cells upon complexation with LBGS is significantly decreased, thus 
decreasing the potential toxicity (Huang, Khor & Lim, 2004). This reinforces the need 
to evaluate separately the carriers and the raw materials, as the former may exhibit 
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different properties, that may encompass different risks (Aillon, Xie, El-Gendy, 870 
Berkland & Forrest, 2009). 
As also observed for another formulation of LBG-based nanoparticles (CS/LBGS), 
which already shown to be promising for oral immunization  (Braz, Grenha, Ferreira, 
Rosa da Costa, Gamazo & Sarmento, 2017), these preliminary results suggest an 
absence of overt toxicity of LBG-only nanoparticles, thus potentiating possible 875 
applications. Nevertheless, it is recognized that further studies need to be performed to 
reach a more accurate conclusion in this regard. 
 
Conclusions 
LBG demonstrated to be a good substrate for the production of charged derivatives, 880 
permitting the synthesis of ammonium, sulfated and carboxylated LBG. Several 
characterization techniques were used to confirm the presence of the new chemical 
groups introduced in each new derivative. 
Using a method of polyelectrolyte complexation, the produced derivatives were applied 
in the preparation of different formulations of LBG-based nanoparticles, reported herein 885 
for the first time. When the negatively charged derivatives (sulfated and carboxylated 
LBG) were used, chitosan was the applied positively charged polyelectrolyte. In turn, 
ammonium LBG was complexed with sulfated LBG to obtain LBG-only nanoparticles. 
The physicochemical characteristics of nanoparticles were highly dependent on their 
composition and on the charge ratios applied in each complexation being performed. 890 
Generally, the observed characteristics, with sizes around 200-400 nm in certain cases, 
and tailorable zeta potential according to setup conditions, are suggested as adequate for 
drug delivery applications.  
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A preliminary toxicological evaluation of LBG derivatives and the produced 
nanoparticles was performed, assessing both the metabolic activity and the cell 895 
membrane integrity of representative intestinal cells (Caco-2) after an exposure of up to 
24 h to concentrations as high as 1 mg/mL. Severe cytotoxicity was found for the 
ammonium derivative of LBG, but this was clearly reverted after the assembly of 
nanoparticles, which evidenced a very mild effect on Caco-2 cell viability. The results 
as a whole indicate the possibility to use the synthesized LBG derivatives to produce 900 
nanoparticles for drug delivery applications. 
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Figure S1 – FTIR spectra of Locust Bean Gum sulfate derivatives (LBGS) obtained in 







Figure S2 – 1H NMR  spectra of (a) LBG, (b) LBGS-M2-B1, (c) LBGC, and (d) 
LBGA; (e) 13C CPMAS spectrum of LBGA; (f) 13C NMR  spectrum of LBGC;  the big 







Figure S3 - Caco-2 cell viability measured by the MTT assay after 3 h exposure to 
increasing concentrations of bulk Locust Bean Gum, purified Locust Bean Gum (LBG) 
and its ammonium (LBGA), carboxylate (LBGC) and sulfate (LBGS) derivatives. Data 
represent mean ± SEM (n ≥ 3, six replicates per experiment at each concentration). 




Figure S4 – Caco-2 cell viability measured by the LDH release assay after 24 h 
exposure to 1 mg/mL solutions of bulk Locust Bean Gum, purified Locust Bean Gum 
(LBG) and its ammonium (LBGA), carboxylate (LBGC) and sulfate (LBGS) 
derivatives. Data represent mean ± SEM (n ≥ 3, three replicates per experiment). * P < 














































Figure S5 – A549 cell viability measured by the MTT assay after 3 h and 24 h exposure 
to increasing concentrations of sulfate locust bean gum (LBGS) derivative. Data 
represent mean ± SEM (n ≥ 3, six replicates per experiment at each concentration). 
Dashed line indicates 70%. * P < 0.05 compared with respective control (DMEM). 
 
 
Figure S6 – Calu-3 cell viability measured by the MTT assay after 3 h and 24 h 
exposure to increasing concentrations of sulfate locust bean gum (LBGS) derivative. 
Data represent mean ± SEM (n ≥ 3, six replicates per experiment at each concentration). 






















































Figure S7 – Caco-2 cell viability measured by the MTT assay after 3 h exposure to 
increasing concentrations of ammonium Locust Bean Gum (LBGA) derivative, sulfate 
Locust Bean Gum (LBGS) derivative and LBGA/LBGS nanoparticles (NP). Data 
represent mean ± SEM (n ≥ 3, six replicates per experiment at each concentration). 




Table S1 – Elemental analysis data from the sulfate (LBGS), carboxylate (LBGC) and 












N --- --- --- --- --- 3.84 
C 25.55 35.06 23.94 28.42 37.39 43.39 
S 7.77 3.50 9.78 7.41 --- --- 
O --- --- --- --- 48.96 --- 
*B1, B2 and B3 refer to LBGS derivatives from batches 1, 2 and 3, respectively; M1 and M2 refer to 
































Table S2 – GPC analysis of purified Locust Bean Gum (LBG), and its ammonium 
(LBGA), carboxylate (LBGC) and sulfate (LBGS-M1) derivatives. 
Polymer Mn (Da) Mw (Da) PdI Rg (nm) 
LBG 327 300 589 100 1.80 71.61 
LBGA 500 600 871 000 1.74 86.05 
LBGC 73 790 119 500 1.62 28.19 
LBGS-M1 21 380 26 510 1.24 14.21 
Mn: number average molecular weight; Mw: weight average molecular weight; PdI: 
polydispersity index; Rg: radius of gyration 
 
